Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis

J Antimicrob Chemother. 1992 Apr:29 Suppl A:59-62. doi: 10.1093/jac/29.suppl_a.59.

Abstract

We evaluated the diffusion of cefpirome into the cerebrospinal fluid (CSF) of 25 patients with bacterial meningitis or ventriculitis who were receiving conventional antibiotic treatment. A single cefpirome dose of 2 g was infused at day 2-3 after the onset of therapy. Concentrations of cefpirome in serum and CSF obtained at 2, 4, 8 or 12 h after the infusion were determined by high-performance liquid chromatography. The mean (+/- S.E.M.) concentrations of cefpirome in CSF ranged from 2.26 +/- 1.16 to 4.17 +/- 0.83 mg/L. These concentrations were higher than the MBCs for the pathogens usually responsible for bacterial meningitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Cefpirome
  • Cephalosporins / cerebrospinal fluid*
  • Cephalosporins / pharmacokinetics
  • Diffusion
  • Female
  • Humans
  • Male
  • Meningitis, Pneumococcal / cerebrospinal fluid*
  • Meningitis, Pneumococcal / drug therapy
  • Meningitis, Pneumococcal / metabolism
  • Middle Aged

Substances

  • Anti-Bacterial Agents
  • Cephalosporins